Monoklonaalsed antikehad (L01XC), immuunosupressandid (L04), teised astmavastased ained süsteemseks kasutamiseks (R03DX)
sihtasutus Põhja-Eesti Regionaalhaigla
Published and bidding deadline .
Integrity Indicators
3 out of 4- Has multiple bidders
- No disputes from bidders or outsiders
- Sellers have not recently made any political party donations
- Bidding period is associated with an increased risk factor
Estimated Cost
Actual Cost
€14.70MDuration
32 daysBidders
3 biddersBids
3 bidsDisputes
0 disputesProcess Type | Open procedure |
---|---|
Offers Revealed At |
Contracts
Roche Eesti Osaühing1. Monoklonaalsed antikehad (L01XC), immuunosupressandid (L04), teised astmavastased ained süsteemseks kasutamiseks (R03DX) Signed with completion deadline . | €6.33M est. €6.33M |
Roche Eesti Osaühing2. Pärnu Haigla Monoklonaalsed antikehad (L01XC), immuunosupressandid (L04), teised astmavastased ained süsteemseks kasutamiseks (R03DX) Signed with completion deadline . | €517,623 est. €517,623 |
TAMRO EESTI OÜ3. Apteegikauba raamleping 7-18-1/48-20 Pärnu Haigla Signed with completion deadline . | €323,757 est. €323,757 |
MAGNUM MEDICAL OÜ4. Apteegikauba raamleping nr 7-18-1/49-20 Pärnu Haigla Signed with completion deadline . | €252,247 est. €252,247 |
MAGNUM MEDICAL OÜ5. Raamleping PERH 215480 Signed with completion deadline . | €4M est. €4M |
TAMRO EESTI OÜ6. Apteegikaup 215480 PERH Signed with completion deadline . | €1.38M est. €1.38M |
Roche Eesti Osaühing7. Apteegikaup PERH Signed with completion deadline . | €338,189 est. €338,189 |